Dune Medical Devices, Inc., announced today that its breakthrough intra-operative tissue assessment tool for early-stage breast cancer surgery, the MarginProbe System, has received Premarket Approval (PMA) by the United States Food and Drug Administration. The technology significantly improves surgeons’ ability to intra-operatively identify
Added:
4340 days ago by
MultiVuVideos
Runtime: 1m56s | Views: 1713 |
Comments: 1
Not yet rated |
|